Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

CLAIRIgene

CLAIRIgene develops gene therapies for neurodegenerative diseases, focusing on precision medicine and epigenome editing.
2019
2-10
Durham, North Carolina, United States
BiotechnologynologyGeneticsPrecision Medicine

Investment Funding

Revenue

$1M to $10M

People

Founders

English